Table 2.

Influenza antiviral supply to medical institutes in Japan

Influenza season	Doses (×10,000)
	NA inhibitors				Polymerase inhibitor
	Zanamivir	Oseltamivir	Peramivir	Laninamivir	Baloxavir
2009–2010	515	859	0.5	–	–
2010–2011	54	240	13	166	–
2011–2012	127	356	26	270	–
2012–2013	110	358	35	280	–
2013–2014	151	336	37	330	–
2014–2015	132	422	37	400	–
2015–2016	40	375	40	368	–
2016–2017	151	453	50	485	–
2017–2018	158	570	60	690	40
2018–2019	59	464	32	289	528

Data adapted from notification on stable supply of influenza antivirals from the Ministry of Health, Labour, and Welfare, Japan.

(NA) Neuraminidase, (–) unapproved.